Aberdeen Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.8M Buy
911,331
+6,474
+0.7% +$119K 0.03% 460
2025
Q1
$15.8M Buy
904,857
+4,167
+0.5% +$72.8K 0.03% 451
2024
Q4
$15.6M Buy
900,690
+25,195
+3% +$436K 0.03% 421
2024
Q3
$16.3M Buy
875,495
+322,255
+58% +$6M 0.03% 433
2024
Q2
$8.52M Sell
553,240
-616,421
-53% -$9.49M 0.02% 539
2024
Q1
$17.3M Buy
1,169,661
+195,311
+20% +$2.88M 0.03% 431
2023
Q4
$13.9M Buy
974,350
+506,011
+108% +$7.22M 0.03% 481
2023
Q3
$6.53M Sell
468,339
-294,369
-39% -$4.1M 0.02% 514
2023
Q2
$8.98M Buy
762,708
+3,966
+0.5% +$46.7K 0.02% 488
2023
Q1
$8.73M Buy
758,742
+8,193
+1% +$94.2K 0.02% 489
2022
Q4
$9.33M Buy
750,549
+413,835
+123% +$5.14M 0.03% 467
2022
Q3
$4.42M Buy
336,714
+287,457
+584% +$3.77M 0.01% 573
2022
Q2
$688K Sell
49,257
-1,415
-3% -$19.8K ﹤0.01% 826
2022
Q1
$755K Buy
50,672
+3,277
+7% +$48.8K ﹤0.01% 854
2021
Q4
$642K Sell
47,395
-523,447
-92% -$7.09M ﹤0.01% 937
2021
Q3
$8.4M Buy
570,842
+24,571
+4% +$362K 0.02% 535
2021
Q2
$9.95M Buy
546,271
+34,030
+7% +$620K 0.02% 502
2021
Q1
$8.9M Buy
512,241
+3,870
+0.8% +$67.2K 0.02% 521
2020
Q4
$8.83M Sell
508,371
-111,655
-18% -$1.94M 0.02% 490
2020
Q3
$8.55M Sell
620,026
-77,598
-11% -$1.07M 0.02% 459
2020
Q2
$10.1M Buy
697,624
+18,004
+3% +$260K 0.03% 415
2020
Q1
$7.42M Sell
679,620
-112,913
-14% -$1.23M 0.02% 441
2019
Q4
$16.9M Buy
792,533
+23,954
+3% +$511K 0.04% 359
2019
Q3
$17.6M Buy
768,579
+277,767
+57% +$6.38M 0.04% 347
2019
Q2
$9.66M Buy
490,812
+5,021
+1% +$98.8K 0.02% 514
2019
Q1
$9.47M Sell
485,791
-144,004
-23% -$2.81M 0.02% 517
2018
Q4
$10.3M Buy
629,795
+187,125
+42% +$3.06M 0.02% 442
2018
Q3
$10.2M Buy
442,670
+419,326
+1,796% +$9.69M 0.02% 483
2018
Q2
$507K Buy
+23,344
New +$507K ﹤0.01% 853